Hospital-acquired infections associated with higher costs and length of stay in discharged cancer center patients
Hidden Costs of Hospital Infections Under New Payment Rules
This retrospective cohort study examined discharged patients at a regional cancer center comparing those with and without hospital-acquired …
Hospital infections under China's new payment rules drive up costs, longer stays, and larger financial gaps for cancer patients compared to …
MDRO detection rates increased during COVID-19 policy phases in Chinese inpatients with hospital-acquired infections
Superbugs Quietly Shifted During COVID, Hospital Data Reveals
A retrospective cohort study of 2,669 adult inpatients with culture-confirmed hospital-acquired infections at a Chinese tertiary hospital fo…
Hospital data shows superbugs quietly shifted during COVID lockdowns, making older adults and long-stay patients face higher infection risks…
Hospital COVID-19 surge associated with cluster of carbapenem-resistant Acinetobacter baumannii cases
Hospital saw drug-resistant bacteria cases rise during COVID-19 patient surge
An observational report from a New Jersey acute care hospital identified a cluster of 34 hospital-acquired carbapenem-resistant Acinetobacte…
A New Jersey hospital saw carbapenem-resistant bacteria cases peak right when COVID-19 patients flooded the facility.
Questions about hospital-acquired infections
Do hospital-acquired infections cause higher medical costs for discharged cancer center patients?
Yes, hospital-acquired infections significantly increase medical costs for discharged cancer center patients, including higher hospitalization costs and greater deficits under the DIP payment model.
Full answer →